Epigeneres Biotech is an early cancer-detection startup.

Basic Information

Epigeneres Biotech offering is working to transform the way cancer care is delivered with real-time, comprehensive and swift insights. In May 2021, Epigeneres Biotech announced their early detection cancer test (co-developed with Tzar Labs, Singapore - a specialised molecular diagnostic company), with a pioneering breakthrough in RNA bio-markers technology which can even detect cancer in Stage Zero (i.e., before tumour formation). The startup is working towards expanding its lab facilities, scaling operations, and development of an AI platform to launch the service in India - a world first. And, continue bringing the best diagnostic technology to patients and providers. See more

Legal Name

:

Epigeneres Biotech Private Limited

Headquarters

:

Mumbai, Maharashtra , India

Founding Date

:

2008

No. of Employees

:

41 to 60

Core Team

:
1.

Ashish Tripathi

Founder & Chairman

2.

Anish Tripathi

Managing Director

3.

Vinay Kumar Tripathi

Chairman

Funding

Total Funding

$6.0M

Investors

:

1.

Moez Daya

2.

Chockalingam Valliappa

3.

Ashish Kacholia

See More

Detail Round Breakdown

Round 1

$6M

Series Name

:

SERIES-B

Date

:

18th Jan 2022

Investors

:
1.

Kotak Investment Advisors

2.

LetsVenture

3.

Moez Daya

See More